CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation

Preclinical and clinical data suggest CD40 activation contributes to renal inflammation and injury. We sought to test whether upregulation of CD40 in the kidney is a causative factor of renal pathology and if reduction of renal CD40 expression, using antisense oligonucleotides (ASOs) targeting CD40,...

Descripción completa

Detalles Bibliográficos
Autores principales: Donner, Aaron J, Yeh, Steve T, Hung, Gene, Graham, Mark J, Crooke, Rosanne M, Mullick, Adam E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014534/
https://www.ncbi.nlm.nih.gov/pubmed/26623936
http://dx.doi.org/10.1038/mtna.2015.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014534/
https://www.ncbi.nlm.nih.gov/pubmed/26623936
http://dx.doi.org/10.1038/mtna.2015.40

Ejemplares similares